معرفی
James McCracken is a tenured Professor of Psychiatry and Biobehavioral Sciences at UCLA's David Geffen School of Medicine. As Director of the Division of Child and Adolescent Psychiatry at the Semel Institute for Neuroscience and Human Behavior, he leads the NIMH-funded Research Center 'Translational Research to Enhance Cognitive Control' focusing on novel treatments for cognitive deficits in child psychiatry. His research spans pharmacogenomics, neurodevelopmental disorders (ASD, ADHD, OCD), and autonomic neurophysiology.
- Key affiliations: Center for Autism Research and Treatment (CART), ADHD Brain Research Institute, Society for Neuroscience
- Research themes: Pharmacologic interventions for neurodevelopmental disorders, white matter sex differences, EEG biomarkers, and genome-wide association studies
- Leadership roles: Principal Investigator for multiple NIMH grants, editorial board member for the Journal of Child and Adolescent Psychopharmacology
His recent publications (2023-2025) emphasize precision medicine in ASD, OCD genetics, and pupillary response as a neurophysiological marker. Awards include the APA Young Psychiatrist Research Award and listings in Best Doctors and Top Doctors databases.
- Scientific Awards
- American Psychiatric Association Young Psychiatrist Research Award
- Best Doctors in America
- America's Top Doctors
- Publications
- Over 150 peer-reviewed articles across child psychiatry
- Leading research in pharmacogenomics and neuroimaging
